Frequently Asked Questions

The initial tests launched by Bilhi Genetics are now available. They test for a genetic predisposition to keloid scars (skin fibrosis).
WHAT IS THE "PREDICTIVE SOLUTION" OFFERED BY BILHI GENETICS?

BILHI Genetics develops predictive tools capable of identifying an individual’s genetic predisposition to fibrosis, inflammations responsible for one in every two deaths by illness in developed countries. The production of genetic tests, manufactured by our partner biomedical laboratory, allows us to identify the risk of developing a fibrosis in the future, for each patient.

Nevertheless, an increased risk does not necessarily mean that an individual with certainly develop an illness. The presence of a genetic anomaly leading to a fibrosis is a necessary, but not sufficient, condition.

The initial tests commercialised in 2018 concern keloid scars, skin fibrosis.

WHAT IS FIBROSIS ?

Fibrosis is a scarring which degenerates on an organ. The fibrous tissue develops following the destruction of existing tissues of an inflammation. It also appears as a response to a wound or scar damage during a scar’s regeneration stage. If the fibrous tissue does not disappear, it evolves into a fibrosis.

WHO DO THE TESTS CONCERN ?

Any individual can be tested for a genetic predisposition to serious fibrosis.

For tests concerning the genetic predisposition to skin fibrosis, any person wishing to undergo a surgical procedure should carry out this test prior to their operation, in order to be aware of their risks of developing a keloid scar.

The liver, once it is attacked by a virus – hepatitis B and C, worms, Schistosoma or fat (NASH) – is damaged. For those who are genetically predisposed, inflammations caused by external factors will evolve into serious fibrosis at severe and sometimes irreversible levels (cirrhosis). Every person should have the right, and freedom, to know their genetic predispositions in order to take preventative action with their doctor, and thus avoid the development of a serious forms of fibrosis.

HOW ARE THESE TESTS DISTRIBUTED ?

Given by medical prescription only, they are not directly distributed by BILHI Genetics to the patient and are therefore not available over the counter.

HOW IS MY DNA SAMPLE TAKEN ?

DNA extraction is carried out in a biomedical laboratory from a saliva sample taken from you at the Doctors.

WHO HAS ACCESS TO MY GENETIC DATA?

Genetic data from those taking a Bilhi Genetics test will be used by our team only. For any person who has given their consent to the reuse of their genetic data for scientific research, they will be conserved by our team, for a time period which will be provided to the patient upon their consent.

WHAT IS THE UTILITY OF THE TESTS PROVIDED BY BILHI GENETICS?

All tests performed are based on Bilhi Genetics know-how, with the goal of providing information about the genetic predisposition of patients, allowing the doctor to use preventative means and suggest therapeutic solutions accordingly. Each patient will also benefit from a personalised follow-up and an adapted therapeutic treatment plan.